They identified that dysregulation of the linc-ROR/miR-145/FSCN1 axis was associated with the therapeutic resistance and EMT transition in LAD cells, thereby providing potential therapeutic strategies for managing drug resistance in patients with LAD (Pan et al., 2017). This evidence concerns the gene LINC-ROR and leukocyte adhesion deficiency.